Biofrontera expects Ameluz sBCC full launch in Q1 2027 while targeting remediation substantially complete by Q2 2027

Washington’s efforts to block Beijing’s access to Nvidia chips could spark a ‘short-lived U.S.-China trade war’ that rattles markets

Akari Therapeutics reports Q3 results

Update: US Equity Indexes Fall as Nvidia Debacle Hits Chipmakers, Long Treasury Yields Jump on 'Elevated' Producer Prices

Bright Mountain Media GAAP EPS of -$0.02, revenue of $11.62M